René Kahn is Associated Scientist of Julius Clinical Research.
René Kahn, MD, is specialised in Psychiatry and in Neurology. In 1995 he received a Fulbright Scholarship for study at Yale and subsequently did a Fellowship in Biological Psychiatry at the Montefiore Hospital and Albert Einstein College of Medicine in New York.
He then moved to the Mount Sinai School of Medicine where he conducted schizophrenia research and became Unit Chief of one of the research units. René Kahn is now Professor and Chair of the Department of Psychiatry and Head of the Division of Neuroscience at the University Medical Center (UMC) Utrecht, The Netherlands. Furthermore, he is Vice-President of the European College for Neuropsychopharmacology and Treasurer of the Schizophrenia International Research Society. He also sits on the Neuroscience and Mental Health Board of the Medical Research Council of the UK and on the scientific advisory group for CNS of the European Medicines Agency. Additionally, he is on the editorial boards of Schizophrenia research, Schizophrenia Bulletin, Early Interventions in Psychiatry and European Neuropsychopharmacology. He published over 350 research papers and book chapters.
|
